Tobacco Harm Reduction

THR is one of the most important public health movements in America.

We are committed to reducing the health impact of our business.

An important way we strive to do so involves support for Tobacco Harm Reduction (THR). We champion tobacco harm reduction in an array of ways, including product development and science, regulatory engagement with the Food and Drug Administration (FDA) and external engagement with interested stakeholders.

Headshot of Sarah Baxter-Wright, Head of Clinical and Behavorial Sciences for Reynolds American, who is committed to Tobacco Harm Reduction.

The importance of
our FDA submissions.

Sarah Baxter-Wright, VP of Science & Regulatory Affairs

Reynolds American believes THR is an opportunity to benefit public health.

THR is an evidence-based public health strategy intended to reduce the health harms associated with using combustible tobacco products.

THR encourages adult smokers uninterested in quitting tobacco altogether to consider using an innovative, alternative nicotine product that may present less risk. These alternative nicotine products include vapor, tobacco heating, oral nicotine, and smokeless.

Tim Nestor

Removing combustion
from the process.

Tim Nestor, EVP of Science & Research

Reynolds American believes Tobacco Harm Reduction (THR) is an opportunity to benefit the public health. The goal of THR is to educate adults who smoke cigarettes about nicotine product alternatives, and to encourage adult smokers to switch if they are uninterested in quitting tobacco altogether.

A basic principle of harm reduction is the product or intervention may not be safe but may be significantly safer than the risky or harmful behavior.

Adult smokers need accurate, science-based information about the continuum of risk and risk differentials among different tobacco products. There is documented evidence of widespread misperceptions of comparative product risk among adults and regarding nicotine.

Our companies are committed to providing adult tobacco consumers with a wide range of options that best fit their preferences. We do not make any health or cessation claims about our portfolio of products. No tobacco product is safe or without risk. The long-term health risks of these products are not known and they contain nicotine, which is addictive.

Our focus on THR, informed by science, is critical in achieving our purpose to deliver A Better Tomorrow™ because a world without harm reduction does more harm.